Pharmafile Logo
Pharmafocus logo
Advanced Search
robina-weermeijer-ihfopazzjhm-unsplash_5

AstraZeneca’s Ultomiris approved in Japan for prevention of relapses in patients with NMOSD

May 30, 2023
Medical Communications AstraZeneca, NMOSD, Neurology, Ultomiris

AstraZeneca has announced that Ultomiris (ravulizumab) has been approved in Japan as a long-acting C5 complement inhibitor for the prevention …

News

FDA approves first oral antiviral to treat adult patients with COVID-19

May 26, 2023
Medical Communications COVID-19, FDA, Infections and infestations, paxlovid

The US Food and Drug Administration (FDA) has announced that it has approved the oral antiviral Paxlovid (nirmatrelvir tablets and …

News

Scientists use AI to find new antibiotic to fight superbug

May 26, 2023
Research and Development AI, Microbiology, WHO, abaucin, antibiotic resistance

Scientists at McMaster University and the Massachusetts Institute of Technology (MIT) have utilised artificial intelligence (AI) in order to discover …

News

ZOLL remedē System receives FDA approval for sleep apnoea treatment

May 25, 2023
Medical Communications Ear Nose & throat, FDA, ZOLL, sleep apnoea

ZOLL Medical Corporation has announced that it has received approval from the US Food and Drug Administration (FDA) for its …

News
volodymyr-hryshchenko-m1hq4ibp9rc-unsplash

BioInvent and Transgene announce positive phase 1a solid tumour trial data

May 25, 2023
Research and Development BioInvent, Oncology, Transgene, clinical trials, oncology, tumours

Sweden-based BioInvent and French Transgene, both biotech companies, have reported positive phase 1a data from a trial studying BT-001 for …

News

ElevateBio announced $401m in Series D financing for cell and gene therapies

May 25, 2023
Sales and Marketing ElevateBio, Financing, cell and gene therapies

US-based cell and gene therapy (CGT) company ElevateBio has announced that, at the end of its Series D financing led …

News
national-cancer-institute-kmvohcb-w5g-unsplash_1

AstraZeneca shares oncology data at ASCO 2023

May 25, 2023
Medical Communications ASCO, AstraZeneca, Cancer, Oncology, oncology

AstraZeneca plans to share data from its oncology pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting on …

News

Artivion receives FDA PMA approval of PerClot; transfers designation to Baxter

May 24, 2023
Medical Communications Artivion, Baxter International, Cardiology, FDA, PMA, PerClot

US cardiac and vascular surgery company Artivion has announced that the US Food and Drug Administration (FDA) has granted a …

News

FDA approves Innoviva’s Xacduro for intravenous use

May 24, 2023
Medical Communications FDA, Infections and infestations, Innoviva, pneumonia

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, has announced that the US Food and Drug Administration (FDA) has approved Xacduro …

News

Rocket Pharmaceuticals granted FDA RMAT designation for gene therapy

May 24, 2023
Medical Communications FDA, Haematology, RMAT, Rocket Pharmaceuticals, gene therapy

Rocket Pharmaceuticals, a US-based biotechnology company, has announced that it has received US Food and Drug Administration (FDA) Regenerative Medicine …

News

Touchlight completes expansion of one of world’s largest DNA manufacturing facilities in London

May 24, 2023
Manufacturing and Production DNA, London, Manufacturing Facility, Touchlight, manufacturing

Touchlight, a company that focuses on pioneering enzymatic DNA production, has announced that it has completed the redevelopment and expansion …

News

More infections from contaminated eyedrops increase death toll

May 23, 2023
Medical Communications FDA, Opthalmology, eyedrops, infections

The US Centers for Disease Control and Prevention (CDC) have released updated data regarding contaminated eyedrops. As of May 2023, …

News

FDA announces acceptance and priority review of NDA for LUMISIGHT imagining agent for breast cancer

May 23, 2023
Research and Development FDA, Lumicell, Oncology, breast cancer, oncology

Lumicell has announced that the US Food and Drug Administration (FDA) has accepted and granted priority review for the New …

News

Grünenthal receives FDA Breakthrough Therapy Designation for knee osteoarthritis drug

May 23, 2023
Medical Communications Breakthrough Therapy Designation, FDA, Grunenthal, Musculo-skeletal disorder, osteoarthritis

German pharmaceutical company Grünenthal has announced that the US Food and Drug Administration (FDA) has awarded it Breakthrough Therapy Designation …

News

FDA approves prescription nasal spray for opioid overdose treatment

May 23, 2023
Medical Communications FDA, Nasal Spray, Opvee, Poisoning and drug dependency, opioids, overdose

The US Food and Drug Administration (FDA) has announced that it has approved Opvee, the first nalmefene hydrochloride nasal spray …

News

Oncimmune Holdings sells businesses to Freenome in £13m deal

May 22, 2023
Sales and Marketing Freenome, Oncimmune Holdings, Oncology, acquisition

UK-based life sciences and immunodiagnostics firm Oncimmune Holdings has announced that it has sold its Oncimmune Limited and Oncimmune Europe …

News

FDA approves new insulin pump and algorithm software for enhanced automated insulin delivery

May 22, 2023
Medical Communications Devices, FDA, diabetes, insulin

The US Food and Drug Administration (FDA) has announced that it has cleared the Beta Bionics iLet ACE Pump and …

News
national-cancer-institute-l8twzt4ccvq-unsplash_1

Swing Therapeutics receives FDA authorisation for digital therapeutic for fibromyalgia

May 22, 2023
Medical Communications CBT, Devices, FDA, Swing Therapeutics, fibromyalgia

Swing Therapeutics has announced that it has received De Novo marketing authorisation from the US Food and Drug Administration for …

News
brano-mm1vipqd0oa-unsplash

Krystal Biotech secures FDA approval for redosable topical gene therapy

May 22, 2023
Medical Communications FDA, Krystal Biotech, Paediatrics, dystrophic epidermolysis bullosa, gene therapy

US-based biotech company Krystal Biotech has announced that the US Food and Drug Administration (FDA) has approved its topical gene …

News
ed-us-k0dml4nmopo-unsplash

FDA committee votes in favour of Pfizer’s RSV vaccine for maternal immunisation

May 19, 2023
Research and Development FDA, Immunology, Pfizer, RSV, Vaccine, maternal immunisation

Pfizer has announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) from the US Food and Drug Administration …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026